Reshaping Rx: Navigating 2025 Drug Pricing Policies Webinar on June 26 at 12:00 PM EDT
Join us for a free webinar as experts break down the latest federal and state policy developments shaping the pharmaceutical landscape in 2025. We’ll explore what these shifts mean for manufacturers, payers, providers, and patients.
Latest News
View All
Topical Ruxolitinib Emerges as Promising Therapy for Diverse Inflammatory Skin Conditions
Epcoritamab Plus Chemoimmunotherapy Yields 87% Response Rate in R/R DLBCL; 65% Proceed to Transplant
Hospital Management Involvement Impacts Health-Related Social Needs Program Adoption
Hospital Management Involvement Impacts Health-Related Social Needs Program Adoption
Managed Care Cast News Roundup: June 17, 2025
Workforce Technology Eases Staffing Shortages in Rural Health Care
Health Equity & Access Weekly Roundup: June 16, 2025
Supreme Court to Rule Whether Pro-Life Pregnancy Center Can Avoid Subpoena
Disparities, Worsening Inequality of Growing RA Burden, Reveals AI-Driven Study
The Growing Role of AI and Other Technology in Cancer Care: Coral Omene, MD, PhD
Unaddressed Adverse Effects Undermine Patient Confidence in Lymphoma, CLL Care Plans: Lorna Warwick
Phase 3 POLARGO Trial Shows Survival Benefit of Polatuzumab-Based Regimen in R/R DLBCL: Matthew Matasar, MD
Lower Socioeconomic Status Tied to Worse Quality of Life in R/R Multiple Myeloma: Francesco Sparano, MSc
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
Barriers to Optimal NF1-PN Care for Patients
Inflation Reduction Act: Clinical Challenges
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
Closing Perspectives
Introducing New Jersey's Premier NCI-Designated Comprehensive Cancer Care Center: Andrew Evens, DO, MBA, MSc
Garadacimab Shuts Down Contact Pathway to Treat HAE: Timothy Craig, DO
Cost and Coverage Issues Drive GLP-1 Discontinuation: Hamlet Gasoyan, PhD
COVID-19’s Hidden Toll: Noah Greenspan, DPT, on Inflammation, Flares, and Recovery
Inflation Reduction Act: Impact on Clinical Pathways for BTK Inhibitors
Data on Duchenne Muscular Dystrophy Treatment From MDA 2025
Epcoritamab Plus Chemoimmunotherapy Yields 87% Response Rate in R/R DLBCL; 65% Proceed to Transplant
Barzolvolimab Shows Long-Term Efficacy in Chronic Spontaneous Urticaria, Improving Patient Quality of Life
Global Hematology Experts Reflect on Key Takeaways From the EHA 2025 Congress
Risk Factors for Financial Toxicity in Health Care
Outcomes for Hospitals Participating in More- and Less-Mature ACOs
Factors Associated With Unplanned Admissions Among Patients With Chronic Conditions
How Value-Based Care With Provider Enablement Improves Maternal and Infant Outcomes in Medicaid
Utilization and Costs Among Oncologists Participating in a Private Insurance Shared Savings Model
Challenges Faced by Medicaid Managed Care Coordinators Working With Members With Substance Use Disorder
Affordable Care Act Enrollment in Texas After Rating Area Adjustments
Weighing Drug Costs and Patient Values in Cancer Care
Cancer Care Innovations Abound, but Access and Equity Are Ongoing Challenges
Translating Best Practices and Ensuring Equitable Care as the Treatment Landscape Evolves
Novel Therapies and Emerging Strategies for HR+/HER2- Metastatic Breast Cancer and the Impact on Patient Outcomes
Application of Recent Data in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Managed Care Insights and Strategies
Emerging Concepts and Approaches in the Treatment of Food Allergy: What Managed Care Professionals Need to Know
Addressing the Gaps and Clinical Challenges in Chronic Lymphocytic Leukemia: Updates and Strategies for Managed Care
Keeping Pace With New Developments in Multiple Myeloma: Updates and Strategies to Optimize Bispecific Antibodies and CAR T-Cell Therapy
Leveraging Novel Therapies to Transform Demodex Blepharitis Care
Novel Agents as Proactive Approaches to Addressing Food Allergy: The Role of the Pharmacist in Guiding Optimal Treatment
Patient-Centered Treatment Plans for Management of Neovascular (Wet) AMD and Diabetic Macular Edema: Insights on Recent Efficacy, Safety, and Real-World Data to Improve Adherence and Outcomes
Innovations in Inflammatory Bowel Disease Therapy: How IL-23 Inhibitors Are Shaping Treatment and Managed Care Approaches
Navigating Next-Generation Therapies for the Management of Acid-Related Disorders
